DaVita Inc

DaVita Inc

DVA - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$11.96B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
DaVita IncDaVita Inc14.4--156%0.8-22.7
$235.25

Target Price by Analysts

26.7% upsideDaVita Target Price DetailsTarget Price
$324.70

Current Fair Value

74.9% upside

Undervalued by 74.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$11.96 Billion
Enterprise Value$24.86 Billion
Earnings per Share$9.72
Beta0.8
Outstanding Shares63,835,000

Return

Return on Equity-155.66%ROE
Return on Assets5.16%
Return on Invested Capital13.08%

Valuation & Multiples

P/E Ratio14.39P/E Ratio
PEG29.8PEG
Price to Sales0.84Price to Sales
Price to Book Ratio10.92Price to Book Ratio
Enterprise Value to Revenue1.75
Enterprise Value to EBIT12.73
Enterprise Value to Net Income27
Total Debt to Enterprise0.54
Debt to Equity-22.66Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 29, 2026
EPS Estimate
$3.57
Consensus analyst estimate
Revenue Estimate
$3.52 B
Consensus analyst estimate

Next Earnings Call

Expected Date
November 4, 2026
EPS Estimate
$3.57
Consensus analyst estimate
Revenue Estimate
$3.52 B
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 44.54%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %2.16%▼ 89.50%
Total Invested$244.33M▼ 98.15%
Investors Holding186▼ 479.00%

About DaVita Inc

78,000 employees
CEO: Javier Rodriguez

DaVita Inc. specializes in delivering vital kidney dialysis treatments to individuals afflicted with chronic kidney failure. The company manages numerous outpatient dialysis clinics, where it not only conducts dialysis sessions but also ...

DaVita Insider Information FAQ

Stockcircle tracks 8 top investors with a current 13F position in DaVita. Notable holders include Warren Buffett and Bridgewater Associates. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 3 top investors increased or opened positions and 7 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 9 open-market insider sales for DaVita in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Stockcircle lists 1 politician trade disclosure tied to DaVita in the last twelve months, drawn from periodic financial disclosure reports. 1 politician traded DaVita in the past year.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.